CMS certification 390050
Allegheny General Hospital
320 East North Avenue, Pittsburgh, PA 15212
Allegheny General Hospital has a CMS overall rating of 3 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on none. Emergency patients spend a median of 4 h 34 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 577 completed surveys, 29% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | PA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 455 visits sampled · US median for EDs of the same volume: 3 h 22 min | 4 h 34 min | 3 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 19 visits sampled | 4 h 43 min | 4 h 57 min | 4 h 17 min |
| Left before being seen Lower is better · 45,126 patients | 3% | 2% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 114 patients | 39% | 60% | 65% |
How Allegheny General Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Allegheny General HospitalThis hospital | 3/5 | 69% | 4 h 34 min | 4 better |
| Magee Womens Hospital of UPMC Health SystemSame city | 4/5 | 78% | 3 h 20 min | 1 better 1 worse |
| UPMC Presbyterian ShadysideSame city | 4/5 | 72% | 3 h 54 min | 8 better 1 worse |
| UPMC St MargaretSame city | 3/5 | 78% | 3 h 53 min | 1 worse |
| UPMC MercySame city | 4/5 | 72% | 3 h 45 min | 3 better 1 worse |
| West Penn HospitalSame city | 3/5 | 77% | 3 h 28 min | 1 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Pittsburgh.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,085 cases | Too few cases | 3.2% | 3.9% |
| Heart attack 88 cases | Too few cases | 11.5% | 11.9% |
| Heart failure 244 cases | Too few cases | 11.3% | 11.1% |
| Pneumonia 165 cases | Too few cases | 14.1% | 15.2% |
| Stroke 754 cases | Too few cases | 11.2% | 11.9% |
| COPD 50 cases | Too few cases | 7.2% | 8.6% |
| Heart bypass surgery (CABG) 127 cases | Too few cases | 2.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.05 likely 0.82 – 1.28 | 1 |
| After hip or knee replacement 41 cases | Too few cases | 4.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 223 cases | No different | 173.3 per 1,000 likely 139.15 per 1,000 – 207.44 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 6,255 cases | No different | 0.51 per 1,000 likely 0.01 per 1,000 – 1.02 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 6,781 cases | No different | 0.17 per 1,000 likely 0 per 1,000 – 0.36 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 7,144 cases | No different | 0.3 per 1,000 likely 0.11 per 1,000 – 0.48 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,757 cases | No different | 2.84 per 1,000 likely 1.65 per 1,000 – 4.03 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,325 cases | No different | 1.6 per 1,000 likely 0.36 per 1,000 – 2.83 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,252 cases | No different | 12.04 per 1,000 likely 8 per 1,000 – 16.09 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,018 cases | No different | 4.38 per 1,000 likely 2.81 per 1,000 – 5.96 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,345 cases | No different | 4.62 per 1,000 likely 1.82 per 1,000 – 7.42 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 660 cases | No different | 1.41 per 1,000 likely 0.04 per 1,000 – 2.78 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,705 cases | No different | 1.23 per 1,000 likely 0.36 per 1,000 – 2.09 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.54 likely 0.31 – 0.86 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.49 likely 0.31 – 0.74 | 1 |
| Surgical site infections after colon surgery | No different | 0.9 likely 0.47 – 1.56 | 1 |
| MRSA bloodstream infections | No different | 0.87 likely 0.49 – 1.42 | 1 |
| C. diff intestinal infections | Better | 0.5 likely 0.35 – 0.69 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 427 cases | Too few cases | 14.9% | 14.4% |
| Readmitted after heart failure 826 cases | Too few cases | 19.4% | 21.3% |
| Readmitted after pneumonia 591 cases | Too few cases | 18.5% | 17.3% |
| Readmitted after COPD 251 cases | Too few cases | 19.1% | 20% |
| Readmitted after heart bypass surgery 209 cases | Too few cases | 9.7% | 11% |
| Readmitted after hip or knee replacement 38 cases | Too few cases | 5.3% | 5.8% |
| Days back in hospital after a heart attack 168 cases | Too few cases | -12.3 days per 100 | — |
| Days back in hospital after heart failure 312 cases | Too few cases | -37.6 days per 100 | — |
| Days back in hospital after pneumonia 184 cases | Too few cases | -21.2 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 500 cases | No different | 15.6 per 1,000 likely 11.9 per 1,000 – 20.6 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 57 cases | No different | 9.2 per 100 likely 6.5 per 100 – 12.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 57 cases | No different | 5.3 per 100 likely 3.5 per 100 – 7.9 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 597 cases | No different | 1 likely 0.8 – 1.3 | — |
1 more measure had too few cases here to report.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $889,365
- 2020 $201,209
- 2021 $336,912
- 2022 $1.2M
- 2023 $175,587
- 2024 $368,443
- 2025 $363,130
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Space rental and facility fees | $62,750 | 9 |
| Medical devices and supplies on long-term loan | $49,225 | 12 |
| Grants | $17,000 | 3 |
| Speaking, teaching and other services | $9,505 | 9 |
| Debt forgiveness | $8,441 | 7 |
| Consulting fees | $5,500 | 1 |
| Education | $840 | 2 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $151,518 | 61 |
| Pfizer INC. | $92,783 | 7 |
| Stryker Corporation | $36,031 | 10 |
| AngioDynamics, Inc. | $13,000 | 1 |
| icotec Medical Inc. | $10,000 | 1 |
| Sirtex Medical Inc | $9,734 | 5 |
| National Marrow Donor Program | $8,130 | 4 |
| Boston Scientific Corporation | $7,000 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 3 OPENLABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB POMALIDOMIDE DEXAMETHASONE EPD OR POMALIDOMIDE BORTEZOMIB DEXAMETHASONE PVD OR… PFIZER INC. | $91,943 |
| An Open-Label, Phase 4 Study to Evaluate the Efficacy and Safety of Dual Targeted Therapy with Vedolizumab Intravenous (IV) and Adalimumab Subcutaneo… Takeda Pharmaceuticals U.S.A., Inc. | $34,273 |
| A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME Takeda Pharmaceuticals U.S.A., Inc. · NCT01990040 | $25,525 |
| Vedolizumab-4054 A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) Takeda Pharmaceuticals U.S.A., Inc. | $22,200 |
| A PHASE 4 STUDY EVALUATING REAL-WORLD USE OF CDPATH?, A CROHN'S DISEASE RISK PREDICTION TOOL Takeda Pharmaceuticals U.S.A., Inc. | $12,192 |
| DOORwaY Study Sirtex Medical Inc · NCT04736121 | $9,734 |
| A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythem… E.R. Squibb & Sons, L.L.C. | $6,532 |
| PROSPECTIVE STUDY ON SURGICAL INTERVENTIONS IN COMPLEX FISTULIZING CONDITIONS (CD-CPAF, CD-RVF, CCF) IN THE US, CANADA, AND EU Takeda Pharmaceuticals U.S.A., Inc. | $2,798 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Allegheny General Hospital
Is Allegheny General Hospital a good hospital?
Allegheny General Hospital has a CMS overall rating of 3 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Allegheny General Hospital?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 577 completed HCAHPS surveys.
How long is the wait in the Allegheny General Hospital emergency room?
Emergency patients spend a median of 4 h 34 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Allegheny General Hospital receive money from drug and device companies?
Drug and device makers reported $363,130 in payments to Allegheny General Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.